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31% of all cardiovascular deaths. [13] The Pan African Pulmonary Hypertension Cohort (PAPUCO) study was established to investigate the epidemiology, causes and natural history of PH in Africa. [14, 15] While the epidemiology of PH in Africa remains largely unknown, it is important to highlight the fact that clinical features of PH are often subtle and nonspecific, especially in the early stages, and may mimic other diseases, so that PH remains undiagnosed. Risk factors, epidemiology, clinical characteristics and outcomes of HF have gender variations that have been described among Caucasians. [16] [17] [18] Recent data from the largest HF registry in SSA suggest that HF was more likely to have been caused by rheumatic heart disease in women and conventional modifiable cardiovascular risk factors in men, although outcomes appeared to be similar. [19] The PAPUCO study presents a broad picture of PH in Africa, [15] but country-specific data on gender differences in the characteristics and outcomes of PH in Africa are still lacking.
Objective
To investigate gender differences in clinical characteristics, echocardiographic findings and outcomes in a cohort of patients with PH in Douala, Cameroon.
Methods

Study design and setting
The PAPUCO study design has been described in great detail, [14] and was registered on ClinicalTrials.gov (NCT02265887). In short, PAPUCO was a prospective pan-African multicentre cohort study of patients newly diagnosed with PH involving 12 specialist centres in SSA including Cameroon. The registry adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines for reporting observational outcomes.
Eligibility
Through convenient sampling, all adult patients (≥18 years of age) who presented to the PAPUCO centre in Douala, Cameroon, with newly diagnosed PH were invited to take part in the study.
Diagnosis of PH
Diagnosis of PH was based on echocardiographic measurement of the right ventricular systolic pressure (RVSP) in the absence of acute right HF, reflecting pulmonary artery systolic pressure in the absence of pulmonary artery stenosis. The RVSP was obtained by measuring the tricuspid regurgitant jet velocity via a pulsed Doppler study of the tricuspid valve. The gradient between right atrium (RA) and right ventricle (RV) was obtained using the simplified Bernoulli equation (4 × [tricuspid jet velocity] 2 ). This value was then added to the RA pressure (fixed value from 5 to 20 mmHg estimated by measuring the inferior vena cava size and its change with spontaneous respiration during echocardiography) for RVSP. A value of >35 mmHg was considered PH. Details of the echocardiographic assessment have been described previously. [14] 
Data collection and study procedures
Patients were interviewed and examined and data were entered on an electronic case report form. [14] General and clinical characteristics included age, sex and risk factors for cardiovascular disease (CVD). A family history of CVD was defined as a documented family history of CVD; hypertension as a systolic (diastolic) blood pressure of ≥140 (90) mmHg, a documented history of hypertension or prescribed antihypertensive medication; presence of diabetes as a fasting blood glucose level of ≥7 mmol/L, a documented history of diabetes or prescribed blood sugar-lowering agents; smoking as never having smoked, being an ex-smoker (if the patient had smoked for at least 3 years in the past, but had stopped at time of presentation) or being a current smoker (patients who smoked at least one cigarette per day at the time of presentation); and alcohol abuse as intake of either more than three (two for women) standard glasses of wine per day or more than ten (five for women) local beers (one local beer contains 28 g of alcohol) per week. The presence of symptoms (dyspnoea, fatigue, cough, palpitation) and signs on physical examination (distended jugular vein, pedal oedema, ascites, S3 gallop, P2 sound) was ascertained. The 6-minute walk test was also performed and the distance covered recorded in patients who had no contraindications. Patients underwent 12-lead electrocardiography, and standard blood results were obtained.
Follow-up and outcome assessment
From the time of recruitment, patients were followed up for 12 months. During the follow-up visit or interview, conducted either in person or via telephone calls, patients and their relatives were questioned about the number of hospitalisations since recruitment (if patients were alive); if they were dead, the time lapse from recruitment to death was recorded.
Data and statistical analysis
Data were analysed using the Statistical Package for the Social Sciences IBM statistical software version 20 for Windows (SPSS Inc., USA). Categorical variables were summarised using frequencies and proportions, while continuous variables were summarised using means and standard deviations or medians with 25th and 75th percentiles. Group comparisons used χ 2 and Fisher's exact (where applicable) tests for categorical variables and the independentsamples t-test for continuous variables. The Kaplan-Meier estimator was used to assess the risk of death during follow-up, with group comparisons based on the log-rank test. The Cox proportional hazard model was used to further investigate the differential effect of gender on mortality. Statistical significance was set at p<0.05. 
Ethical considerations
Results
Sociodemographic characteristics, risk factor profile and clinical findings
During the study period, 1 855 patients underwent echocardiographic examination. Of these, 130 (7.0%) had an RVSP >35 mmHg and were included in the study. All were of black African descent, and 71 (54.6%) were women. Table 1 summarises the baseline sociodemographic characteristics, risk factor profile and clinical findings of the cohort on a gender-specific basis. The mean age of the patients was 59 years, with no difference between men and women (p=0.76). Men were more likely to be in the age group 55 -64 years, while the majority of women were aged ≥75 years. Fig. 1 depicts the age distribution of the study population according to gender. Cardiovascular risk factors RESEARCH were prevalent in our cohort, hypertension (55.9% v. 52.1%), diabetes (15.3% v. 14.1%) and hypercholesterolaemia (16.9% v. 14.1%) being similarly distributed between men and women. Alcohol abuse (44.1% v. 14.1%) and current or previous smoking (32.2% v. 11.2%) were significantly more common in men (both p<0.01), while exposure to indoor cooking fumes (36.6% v. 3.4%) and previous tuberculosis (TB) infection (11.3% v. 1.7%) were more common in women (both p<0.03). At presentation, similar proportions of men and women were in New York Heart Association (NYHA) classes III and IV (74.6% v. 70.4%), although S3 gallop (30.9% v. 11.9%; p=0.011) was more common in women. Mean systolic blood pressure (134 mmHg v. 125 mmHg; p=0.041) and mean pulse pressure (53.9 mmHg v. 44.9 mmHg; p=0.01) were also significantly higher in women than in men. Table 2 summarises electrocardiographic and laboratory findings at presentation. No gender-specific differences were identified on RESEARCH electrocardiography. The mean haemoglobin concentration was lower in women than in men (10.4 g/dL v. 12.4 g/dL; p=0.042), while apparent differences in other biological characteristics did not reach statistical significance. Table 3 summarises the echocardiographic findings. Compared with women, men had significant left ventricular (LV) systolic dysfunction: mean LV end-systolic diameter 47.3 mm v. 38.6 mm, (p<0.01), mean LV ejection fraction 42.6 v. 51.5 (p=0.01), and mean fractional shortening 21.4 mm v. 28.6 mm (p=0.01). Overall the mean RVSP was 55.6 mmHg without gender difference. A borderline difference in the severity of mitral regurgitation was apparent between men and women (p=0.070). Table 4 summarises subgroup classification of PH, severity at presentation and outcome in a subset of patients. Overall, 78.5% (n=102) of the cohort had PH caused by left heart disease, which was similar in men and women (81.3% v. 76.0%; p>0.05). Chronic thromboembolic PH was the least observed cause of PH in this study population (one patient). The majority (76.9%) of patients had moderate or severe PH (RVSP ≥45 mmHg). No difference was found between men and women.
Electrocardiographic, laboratory and echocardiographic findings
Aetiology of pulmonary hypertension, severity grading and outcome
We recorded 29 deaths (20.3%) and 15 readmissions (11.5%) after a median follow-up of 60 days (interquartile range 30 -150) . The in-hospital mortality rate was 18.5%. Kaplan-Meier estimator (log rank 1.1; p=0.30) (Fig. 2) as well as age-adjusted Cox regression models did not show a significant difference in survival between men and women (hazard ratio 0.82 (95% confidence interval 0.38 -1.74); p=0.601) ( Table 5 ).
Discussion
In this prospective cohort of patients with PH from specialised centres in Douala, Cameroon, a number of gender-related differences were observed. At baseline, men had smoking as a modifiable risk factor for CVD, while women had greater exposure to indoor cooking fumes. Both presented at advanced stages of the disease, men seeming more affected. Anaemia was more common in women, while RESEARCH echocardiographic LV systolic dysfunction was frequent in men. Left heart disease was the main cause of PH in the two groups, and survival rates were similar. The overall mean age in our study was 58 years, which is two decades younger than in reports from most industrialised countries, [5] but close to the 53 years reported in a recent study from Nigeria. [12] Women in our study were older than men, which has also been reported among Caucasians. [20] The mean age was, however, higher than that reported from a Portuguese PH registry. [21] While relatively younger age appears to be a striking feature of our cohort of SSA patients with PH, it should be noted that it is also a common finding in patients with HF, with relatively young patients being affected (median age 55 years). [22] One likely explanation is the over-representation of group 2 PH caused by left heart disease in our cohort, whether as a result of left HF or valvular heart disease, which usually occurs at a younger age.
The most frequent risk factors/comorbidities in the overall cohort were hypertension, diabetes, alcohol abuse and smoking. Alcohol abuse and active smoking were more common among men. This is similar to findings from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) registry on pulmonary arterial hypertension in the USA, 
RESEARCH
where hypertension was a frequent comorbidity. [23] Similarly, a cross-sectional survey in Tanzania recently highlighted the fact that women had a 50% lower odds of hypertension compared with men. The slight predominance of conventional modifiable risk factors for CVD among men in this cohort is similar to findings among patients with HF in Africa, [19] but is contrary to reports from the EuroHeart Failure Survey. [24] The finding of hypertension as the most frequent CVD risk factor in our cohort is unsurprising, as over three-quarters of the patients had group 2 PH caused by left heart disease, which in our setting is frequently hypertensive heart disease with a final progression to left HF. [22.25] Exposure to indoor cooking fumes, especially from burning wood, was significantly more frequent among women. It is common for women in Africa to cook over an open fireplace, particularly in rural settings. However, this is not the case in middle-and high-income countries. The contribution of this exposure to the occurrence, severity and outcome of PH in African women still needs to be explored, and group 3 PH, caused by chronic lung disease, more intensively investigated. However, this requires additional equipment such as high-resolution computed tomography and lung function testing. Among the risk factors for chronic lung disease, a history of previous TB infection was also significantly more common in women than in men in our cohort. Unfortunately, the relationship to HIV infection (with a higher incidence of TB in HIV-infected individuals) could not be investigated, because HIV testing is not performed as a standard test in cardiac patients in Cameroon. Also, women were generally more obese than men and, although obesity has been independently associated with PH, this finding could simply reflect the high prevalence of female obesity in our population. [26] The reasons for some of our findings are unclear, but it remains possible that exposure of women to PH risk factors in our setting may be more complex and multifactorial than that of men, owing to a combination of the above risk factors (chronic lung disease and HIV) in varying degrees. The majority of our patients, particularly men, presented at advanced stage of the disease (NYHA III/IV). This is similar to reports from Nigeria, [12] Australia [5] and Portugal, [21] where most patients present with features of advanced HF. This late presentation is probably due to nonspecific symptoms of PH in the early stages, as well as limited availability of diagnostic tools. Anaemia was observed more often in women than in men. Similar observations were made in The sub-Saharan Africa Survey of Heart Failure (THESUS-HF) registry, probably related to menstruation. [19] Atrial fibrillation, sinus tachycardia and LV hypertrophy were the main electrocardiographic abnormalities in our cohort. Although previous reports and clinical guidelines suggest that patients with PH have RV hypertrophy on electrocardiograms, [2, 27] this was not the case in our cohort, probably owing to the high prevalence of hypertension, LV dysfunction leading to LV hypertrophy; this consequently increases the left atrial pressure and may predispose to arrhythmias such as atrial fibrillation. [22, 25] Supraventricular 
arrhythmias such as atrial fibrillation are, however, said to occur in advanced stages of PH and are associated with clinical deterioration, [28] which probably explains the high case fatality in our cohort. On echocardiography, men had significant LV systolic dysfunction compared with women. With hypertension generally being more prevalent in men, it is likely that the observed LV dysfunction in men was due to hypertensive heart disease (as the hypertrophy as seen on the electrocardiogram). In contrast is the observation of a lower mean systolic blood pressure in men, which could potentially reflect advanced LV dysfunction and HF. Mitral valve lesions (stenosis and regurgitation) were frequent among women, with aortic lesions being more common in men. This is fairly consistent with the high prevalence of rheumatic heart disease in SSA [29] and its previously reported predominance in female HF patients in the region. [19] Although no significant gender difference in survival was observed, the high mortality rate from PH in this setting is worrying. Doctors in the region should have a high index of suspicion, and screening tools need to be put in place.
Study limitations and strengths
This study had a number of limitations. First, echocardiography was the main diagnostic tool used for the diagnosis of PH, as opposed to gold-standard RHC. This limitation of our registry has been discussed previously [14] and has to do with the challenges of diagnosing PH in the resource-limited settings that are so common in SSA. Echocardiography is much more affordable and available, and poses almost no risk compared with the invasive procedure of RHC. [30] Furthermore, the diagnostic accuracy of echocardiography has been reported in a meta-analysis and it is now widely recognised as a screening tool for PH. [31] The study was also conducted in specialised referral cardiovascular centres, and we acknowledge that patients who could not afford these services could have been missed; interpretation and generalisability of our results are therefore limited, as they probably represent findings from the participating centres. The small sample size may also limit the generalisability of our observations and disparities between genders, especially in respect of mortality and hospitalisation.
Our study nevertheless has merit in that it is among the few studies that have attempted to explore gender differences in epidemiology, clinical characteristics and echocardiographic features of patients with PH in a resource-limited setting. The prospective design also gives strength to the results obtained, and as an echocardiographic study it can be compared with many other studies worldwide that have used the same diagnostic modality. Our findings are relevant for both clinicians and public health experts, as they provided data on baseline clinical characteristics of PH as well as on potential risk factors. Clinicians should increase their index of suspicion, and public health experts should plan for risk factor interventions and allocation of resources.
Conclusion
Gender differences in risk factors and comorbidities of patients with PH in Africa exist, with modifiable cardiovascular risk factors in men as opposed to valvular heart disease in women. Interventions for the control of PH in men should target cardiovascular risk factors such as hypertension, alcohol abuse and smoking, while those for women should be directed towards chronic lung disease and rheumatic heart disease, as well as hypertension. Mortality from PH in our cohort was high, and there is a need for larger multicentre studies to confirm our findings as well as to explore further gender-related differences in PH in Africa. The different baseline characteristics observed could potentially reveal different pathogeneses of PH in men and women in our setting, which need further investigation.
